Regent Investment Management LLC Apellis Pharmaceuticals, Inc. Transaction History
Regent Investment Management LLC
- $373 Million
- Q4 2022
A detailed history of Regent Investment Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Regent Investment Management LLC holds 21,309 shares of APLS stock, worth $817,413. This represents 0.3% of its overall portfolio holdings.
Number of Shares
21,309
Previous 21,309
-0.0%
Holding current value
$817,413
Previous $1.46 Million
24.26%
% of portfolio
0.3%
Previous 0.42%
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
337Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$578 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$436 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$426 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$211 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.21B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...